Summary by Futu AI
On January 6, 2025, BlackRock, Inc. significantly increased its Shareholding in PA GOODDOCTOR (Ping An Health Medical Technology). According to the transaction disclosure under Rule 22 of Hong Kong's "Code on Takeovers and Mergers," BlackRock conducted three Buy transactions that day, purchasing a total of 7,359,112 shares, with transaction prices between 6.2588 and 6.2600 Hong Kong dollars per share.After the transactions were completed, BlackRock's shareholding in PA GOODDOCTOR increased to 32,465,932 shares, accounting for 2.9018% of that class of securities. Notably, the largest single transaction involved the purchase of 7,337,312 shares, classified as collateral received, representing a net change in collateral.As BlackRock holds the common shares of the offeror, it is considered a contact person of the offeror according to Class (6). These transactions were conducted on behalf of fully discretionary investment clients' accounts. The disclosing form was received by executives after business hours on January 7, 2025, which could trigger a mandatory general offer.